El-Khayat HA, Soliman NA, Tomoum HY, et al. Reproductive hormonal changes and catamenial pattern in adolescent females with epilepsy. Epilepsia 2008;49:1619-26.
Reddy DS. Role of neurosteroids in catamenial epilepsy. Epilepsy Res 2004;62:99-118.
Scharfman HE, MacLusky NJ. The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female. Epilepsia 2006;47:1423-40.
Reproductive Development & Function of the Female Reproductive System. In: Barrett KE, Barman SM, Boitano S, et al, eds. Ganong’s Review of Medical Physiology (24th ed.). New York: McGraw-Hill, 2012:391-418.
Normal menstrual cycle. (Accessed December 10, 2014, at http://upload.wikimedia.org/wikipedia/commons/2/2a/MenstrualCycle2_en.svg.)
Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia 1997;38:1082-8.
Pennell PB. Hormonal aspects of epilepsy. Neurol Clin 2009; 27:941-65.
Levin ER, Hammes SR. Estrogens and progestins. In: Brunton LL, Chabner BA, Knollmann BC, et al, eds. Goodman & Gilman’s pharmacological basis of therapeutics (12th ed.). New York: McGraw-Hill, 2011;1163-94.
Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 2003;61:S35-42.
Sabers A, Ohman I, Christensen J, et al. Oral contraceptives reduce lamotrigine plasma levels. Neurology 2003;61:570-1.
Reimers A, Helde G, Brodtkorb E. Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations. Epilepsia 2005;46:1414-7.
Herzog AG, Blum AS, Farina EL, et al. Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use. Neurology 2009;72:911-4.
De Haan GJ, Edelbroek P, Segers J, et al. Gestationinduced changes in lamotrigine pharmacokinetics: a monotherapy study. Neurology 2004;63:571-3.
Guberman A. Hormonal contraception and epilepsy. Neurology 1999;53:S38-40.
Herzog AG. Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology 1986;36:1607-10.
Herzog AG. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 1995;45:1660-2
Herzog AG. Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology 1999;52:1917-8.
Herzog AG, Fowler KM, Smithson SD, et al. Progester one vs placebo therapy for women with epilepsy: A randomized clinical trial. Neurology 2012;78:1959-66.
Feely M, Calvert R, Gibson J. Clobazam in catamenial epilepsy. A model for evaluating anticonvulsants. Lancet 1982;2:71-3.
Lim LL, Foldvary N, Mascha E, et al. Acetazolamide in women with catamenial epilepsy. Epilepsia 2001;42:746-9.
